Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives.
Molecular neurobiology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAlzheimer DiseaseQuercetinBlood-Brain BarrierAnimalsDrug Delivery SystemsNanoparticlesBlood–brain barrierMolecular mechanismsNanoformulationNeuroinflammationOxidative stressTargeted drug delivery
Come citare questo studio
M Yasmin Begum, Manickam Rajkumar, Prabha Govindaraj, Sundar Velmani, Prabhakaran Rajkumar, Parappurath Narayanan Sudha, Mona Alhamod, Hamoud Alotaibi. (2026). Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives.. Molecular neurobiology. DOI: 10.1007/s12035-026-06188-x
Consulta la pubblicazione originale ↗